Charles A Scanga Selected Research

Charles A Scanga Research Topics

16	Tuberculosis (Tuberculoses) 02/2022 - 12/2003
16	Infections 01/2020 - 08/2003
3	Granuloma 10/2022 - 01/2017
2	Pulmonary Tuberculosis 01/2020 - 08/2014
2	Pneumonia (Pneumonitis) 01/2017 - 01/2017
2	Inflammation (Inflammations) 01/2017 - 01/2007
1	Lung Diseases (Lung Disease) 01/2022
1	COVID-19 01/2020
1	Coinfection 01/2017
1	Influenza in Birds (Avian Flu) 01/2017
1	Cytokine Release Syndrome 01/2017
1	Toxoplasmosis 06/2002

7	VaccinesIBA 10/2022 - 05/2012
5	CytokinesIBA 01/2017 - 04/2005
5	Interleukin-12 (IL 12)IBA 12/2005 - 06/2002
4	AerosolsIBA 01/2020 - 12/2003
3	AntigensIBA 01/2019 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2003
3	LigandsIBA 01/2017 - 12/2003
3	Messenger RNA (mRNA)IBA 01/2007 - 08/2003
3	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2005 - 11/2003
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 01/2017
2	EnzymesIBA 01/2017 - 03/2010
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Clofazimine (Lamprene)FDA Link 02/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	BCG Vaccine FDA Link 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Heme Oxygenase-1IBA 01/2017
1	PeptidomimeticsIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	AlbuminsIBA 01/2017
1	Tuberculosis VaccinesIBA 01/2017
1	Integrin alpha4beta1 (VLA-4)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	IntegrinsIBA 01/2017
1	AntioxidantsIBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016
1	Histocompatibility Antigens Class IIBA 05/2012
1	Leukotriene A4IBA 03/2010
1	EicosanoidsIBA 03/2010
1	HydrolasesIBA 03/2010
1	AcidsIBA 01/2007
1	lipoxin A4IBA 06/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2005
1	LipoxinsIBA 06/2005
1	Myeloid Differentiation Factor 88IBA 11/2003
1	Toll-Like Receptor 2IBA 11/2003

1	Intravenous Administration 01/2020
1	Therapeutics 01/2017